![2022 WCLC 肺癌EGFR標靶交響曲!新一代標靶藥物真實世界數據與專家點評 2022 WCLC 肺癌EGFR標靶交響曲!新一代標靶藥物真實世界數據與專家點評](/tw/sites/default/files/2023-05/47_SC-TW-00289.png)
Reporting adverse events
- Patient Safety and Pharmacovigilance
Tel.: (02) 2503-2636
Fax: (02) 2503-4845
E-mail: PV_local_Taiwan@boehringer-ingelheim.com
Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.